EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies

Hua Zhang, Liwen Zhang, Chang Liu

Current Molecular Pharmacology · 2026 · 19 (1) · 225-227

DOI: 10.1016/j.cmp.2026.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2026. Verfasst von Hua Zhang und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, H., Zhang, L., & Liu, C. (2026). Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies. Current Molecular Pharmacology, 19(1), 225-227. https://doi.org/10.1016/j.cmp.2026.09.002

Vancouver

Zhang H, Zhang L, Liu C. Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies. Current Molecular Pharmacology. 2026;19(1):225-227. doi:10.1016/j.cmp.2026.09.002

BibTeX
@article{Zhang2026,
  author = {Zhang, Hua and Zhang, Liwen and Liu, Chang},
  title = {Accelerating drug discovery targeting KRAS mutations with advanced high-throughput hit identification technologies},
  journal = {Current Molecular Pharmacology},
  year = {2026},
  volume = {19},
  number = {1},
  pages = {225--227},
  doi = {10.1016/j.cmp.2026.09.002}
}
Kostenlos starten →